Tilray Brands, Inc. Deferred Tax Liabilities, Intangible Assets
Tilray Brands, Inc. (TLRY) had Deferred Tax Liabilities, Intangible Assets of $8.26 million as of 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets · last filed 2026-07-28
- 2026-05-31: Deferred Tax Liabilities, Intangible Assets $8.26M.
- 2025-05-31: Deferred Tax Liabilities, Intangible Assets $1.42M.
- 2024-05-31: Deferred Tax Liabilities, Intangible Assets $218.02M.
- 2023-05-31: Deferred Tax Liabilities, Intangible Assets $225.46M.
| Period end | Deferred Tax Liabilities, Intangible Assets |
|---|---|
| 2026-05-31 | $8.26M 10-K · filed 2026-07-28 |
| 2025-05-31 | $1.42M 10-K · filed 2026-07-28 |
| 2024-05-31 | $218.02M 10-K · filed 2025-07-29 |
| 2023-05-31 | $225.46M 10-K · filed 2024-07-30 |
| 2022-05-31 | $305.58M 10-K · filed 2023-07-26 |
| 2021-05-31 | $376.23M 10-K · filed 2022-07-28 |
| 2020-12-31 | $48.46M 10-K · filed 2021-02-19 |
| 2020-05-31 | $69.58M 10-K · filed 2022-07-28 |
| 2019-12-31 | $54.81M 10-K · filed 2021-02-19 |
| 2019-05-31 | $73.45M 10-K · filed 2021-07-28 |
| 2018-12-31 | $289.00K 10-K · filed 2021-02-19 |
| 2017-12-31 | $129.00K 10-K · filed 2020-03-02 |
| 2016-12-31 | $144.00K 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |